21 Weekly paclitaxel and three weekly docetaxel appear active and well-tolerated in third and fourth-line advanced NSCLC patients

A Pender, I Letsa, A Reid,T Waddell,K Nimako,D Tan, I Xynos,B Ayite,K Priest, S Watson, Z Stewart, J Severn,S Popat,M Obrien

Lung Cancer(2012)

引用 0|浏览7
暂无评分
关键词
weekly paclitaxel,weekly docetaxel,well-tolerated,fourth-line
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要